Nursing Articles

Nursing > legal nurse consultant > Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care

Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care

 

 Carolyn Tarrant*1, Paul Sinfield2, Shona Agarwal2 and Richard Baker2

Address:

Sciences, University of Leicester, 22-28 Princess Road West, Leicester, LE1 6TP, UK

Email: Carolyn Tarrant* - ccp3@le.ac.uk; Paul Sinfield - pks4@le.ac.uk; Shona Agarwal - sa144@le.ac.uk; Richard Baker - rb14@le.ac.uk

* Corresponding author1Department of Health Sciences, University of Leicester, 2nd Floor, Adrian Building, Leicester, LE1 7RH, UK and 2Department of Health

Abstract

Background:

of patients with prostate cancer, however there is concern that the specialist nurse role is under

threat in the UK due to financial pressures in the NHS. This study explored the role and value of

specialist nurses in prostate cancer care via a survey and patient interviews.Specialist nurses may play an important role in helping to improve the experiences

Methods:

across the UK (289/481, 60%), investigated whether patients who saw a specialist nurse had

different experiences of information provision and involvement in decision-making, to those who

did not. Qualitative interviews were also carried out with 35 men recently tested or treated for

prostate cancer, recruited from two hospitals in the UK. Interviews explored patients' views on

the role and value of the specialist nurse.This paper reports findings from two studies. A survey of patients from three hospitals

Results:

experiences of receiving written information about tests and treatment, and about sources of

advice and support, and were more likely to say they made the treatment decision themselves. In

interviews, patients described specialist nurse input in their care in terms of providing information

and support immediately post-diagnosis, as well as being involved in ongoing care. Two key aspects

of the specialist nurse role were seen as unique: their availability to the patient, and their ability to

liaise between the patient and the medical system.Survey findings indicated that patients who saw a specialist nurse had more positive

Conclusion:

patients with prostate cancer, and highlights the importance of maintaining specialist nurse roles in

prostate cancer care.This study indicates the unique role that specialist nurses play in the experience of

Background

The care that cancer patients in the UK receive has been

under scrutiny, and patients with prostate cancer have

been found to report less positive experiences of care than

patients with other types of cancer. Patients with prostate

cancer are less likely to have the opportunity to discuss

side effects of treatment, to understand how well their

treatment has gone, or to get information about support

and self help groups, than patients with other types of

cancer [1].

Published: 27 March 2008

BMC Health Services Research

Received: 24 August 2007

Accepted: 27 March 2008

This article is available from: http://www.biomedcentral.com/1472-6963/8/65

© 2008 Tarrant et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.2008, 8:65 doi:10.1186/1472-6963-8-65

BMC Health Services Research

Page 2 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

The role of the specialist nurse in prostate cancer care can

be varied, but is primarily focused on the provision of

information and support to patients [2]. Specialist nurse

involvement may help to improve the experiences of

patients with prostate cancer, and may be associated with

positive outcomes [3-5]. The NICE Improving Outcomes

Guidance on urological cancers emphasised the importance

of specialist nurses in prostate cancer care [6], however,

prostate cancer patients have lower levels of access to

specialist nurses than do patients with other types of cancer

[1]. Individuals and organizations involved in prostate

cancer care have pointed to the availability of specialist

nurses as a key priority for government action [7].

Set against this, current financial pressures in the NHS are

threatening specialist nurse posts, with specialist nurses

expressing concern that they may face losing their jobs, or

may have to give up some or all of their time in their specialist

role to work as generalist nurses on hospital wards

in order to cover staffing shortages [8-10]. The role of specialist

nurses in dealing with information, advice and

emotional support, may appear to be "less tangible and a

relative 'luxury' when compared with ward-based nurses"

[11], leading to their roles being reviewed when resources

are constrained. However, Richardson [12] has identified

that patients with prostate cancer are more likely to report

unmet needs if they do not see a specialist nurse.

There is a need for further research into the role and value

of specialist nurses in prostate cancer care, to support decisions

about the importance of maintaining and increasing

the availability of specialist nurses to patients with prostate

cancer.

This paper reports findings from two linked studies carried

out as part of a larger study to develop a measure of

patient experience of prostate cancer care [13]. A questionnaire

survey of patients' experiences of prostate cancer

care provided an opportunity to investigate whether

patients who saw a specialist nurse had more positive

experiences of care than those who did not. Qualitative

interviews with patients and carers further explored

patient perceptions of the role and value of the specialist

nurse in prostate cancer care.

Methods

Two methodological approaches were used: a quantitative

patient survey and a qualitative investigation of patients'

experiences.

A questionnaire on experiences of prostate cancer care was

mailed to a sample of 481 patients who had been tested

or treated for prostate cancer during the previous two

years at one of three hospitals in different regions of the

UK. Patients were randomly selected from clinic lists for

several clinics at each hospital, including patients who

were undergoing different types of treatment, and were at

different stages in their care. There were no age restrictions

put on the sample. Clinic staff were asked to check the lists

and exclude any patients who had not been diagnosed, or

who were not aware of their diagnosis.

The questionnaire was developed as part of the larger

study, and was based on themes identified through interviews

of patients with prostate cancer and health professionals

[13]. The questionnaire included a question about

whether the patient had seen a specialist nurse following

their diagnosis. It also included a number of questions

relating to the provision of information about treatment

options, patient involvement in the treatment decision,

and the provision of information about sources of advice

and support. Univariate analysis (ANOVA) was used to

identify whether patients who saw a specialist nurse had

different experiences of these issues to patients who did

not see a specialist nurse.

In order to further explore the role of the specialist nurse

in prostate cancer care, an analysis of patient interviews

undertaken as part of the larger study [13] was also carried

out. Interviews were with prostate cancer patients from

two hospitals in the East Midlands, UK, recruited using a

quota sampling frame to ensure that patients at different

stages of disease and treatment, and in different age and

ethnicity groups, were included. Patients were identified

from attendees at Urology Clinics and from hospitals'

patient registers. In addition, two cancer charities were

asked to contact patients from ethnic minority groups to

ensure that both South Asians and Afro-Caribbeans were

represented in the sample.

The interviews were semi-structured and aimed to explore

patients' experiences over the course of their care, including

initial GP visit(s), further testing, diagnosis, treatment,

and ongoing monitoring (where relevant). The interviews

did not specifically aim to explore the role of the specialist

nurse, although the role and value of the specialist nurse

emerged as a theme. Interviews were carried out in

patients' own homes; in some cases, the patient's wife or

partner was present and also participated in the interview.

The interviews were audiotaped and transcribed verbatim,

then transferred into the software package NUD*IST 6,

and analysed using the Framework approach [14]. Analysis

was undertaken to specifically explore the role and

value of the specialist nurse in patients' experiences of

prostate cancer care. All quotes used have been anonymised,

and a patient identification number is given in

brackets at the end of each quote.

BMC Health Services Research

Page 3 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

Results

Participants

The questionnaire was completed by 289 patients (60%).

Of these, 252 (87.2%) had seen a specialist nurse, and 37

(12.8%) had not. The characteristics of survey responders

are given in Table 1. Patients who did not see a specialist

nurse were more likely to be in the 75+ age group than

patients who did see a specialist nurse (

0.001), but did not differ significantly in terms of ethnicity,

health status, treatment type, or time since most recent

treatment.

Qualitative interviews were carried out with 35 patients;

in 10 of the interviews the wife/partner was also present.

The characteristics of the patients interviewed are given in

Table 2.F = 8.20; p <

Findings – questionnaire survey

Results from the questionnaire survey were analysed to

explore whether patients who saw a specialist nurse had

different experiences of care to patients who did not see a

specialist nurse. Table 3 shows the odds ratios for questions

on patient experience of care, comparing patients

who did see a specialist nurse with those who did not,

adjusted to take patient age into account. An odds ratio

greater than one indicates that a positive response to the

question was more likely in the first group (who did see a

specialist nurse) than in the second group (who did not

see a specialist nurse).

Patients who saw a specialist nurse were significantly

more likely to say that they were given enough written or

printed information about their test results and treatment

options (Table 3, questions 1, 2, 3, 7 and 8). They were

also more likely to feel that their treatment options were

clearly explained (Table 3, question 4). Patients who saw

a specialist nurse were much more likely to report that

they had been given enough information about sources of

help (Table 3, question 13). There were no significant differences

in terms of whether side effects of treatment were

clearly discussed, or whether the doctor or nurse discussed

with them why other treatment options were not suitable

(Table 3, questions 5 and 6).

Patients who saw a specialist nurse were more likely to say

that they made the treatment decision themselves (Table

3, question 9), although there was no significant difference

between the groups in the extent to which they felt

involved in the treatment decision. Patients who saw a

specialist nurse were more likely to have been told that

they could discuss the treatment decision again, and could

change their mind about treatment (Table 3, questions 11

and 12).

Findings – qualitative interviews

The analysis of the qualitative interviews explored the role

of the specialist nurse in prostate cancer care, with the aim

of understanding the differences in experiences of patients

who did and did not see a specialist nurse, and the perceived

value of the specialist nurse role.

Role of the specialist nurse in patients' experiences of prostate

cancer care

Most patients first saw the specialist nurse after being

given their diagnosis by a consultant. At this stage patients

often had to contemplate their diagnosis, consider a range

of treatment options, and make a treatment decision.

Here the role of the specialist nurse involved providing

time for the patient to talk about the diagnosis and ask

questions, and providing information about the diagnosis,

treatment options, and support services.

Table 1: Characteristics of questionnaire survey responders (n = 289)

Saw specialist nurse

number (%)

Did not see specialist

nurse number (%)

Total number (%)

Age

55–64 83 (32.9) 7 (18.9) 90 (31.1)

65–74 121 (48.0) 14 (37.8) 135 (46.7)

75 or over 29 (11.5) 16 (43.2) 45 (15.6)up to 54 6 (2.4) 0 6 (2.1)

Ethnicity

South Asian 5 (2.0) 2 (5.4) 7 (2.4)

African/Caribbean 21 (8.3) 0 21 (7.3)

Other 1 (0.4) 0 1 (0.3)White 211 (83.7) 35 (94.9) 246 (85.1)

Stage of disease/

treatment

Newly diagnosed (not yet

treated)

0 0 0

Being actively monitored without

treatment

38 (15.1) 10 (27.0) 48 (16.6)

Had curative treatment (e.g.

prostatectomy, radiotherapy)

147 (58.3) 14 (37.8) 161 (55.7)

Having hormone therapy 52 (20.6) 11 (29.7) 63 (21.8)

BMC Health Services Research

Page 4 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

[Consultant] said to go with the nurse and she'll

explain everything to me, which she did, and made a

good job of it ... I was with her about 20 minutes, half

an hour...to have things explained and you had the

opportunity to ask questions (38)

She was able to talk about the support services that

were available in the event of having different options

(43)

As well as playing an important role for patients immediately

post-diagnosis, specialist nurses provided ongoing

support for many patients during the course of treatment

and follow-up, through their availability for consultation

either by telephone or in person, and in some cases,

through arranging patient support groups:

I will go back and be checked from time to time and

honestly, my nurse specialist is always there and I will

require that service for some time to come (49)

The oncology nurse does run once a month in one of

the local pubs in the town a sort of a prostate get

together and has done for three or four years probably

(15)

Unique features of the specialist nurse role

Analysis of patient interviews highlighted the unique

nature of the specialist nurse role, and the value of this

role to patients. Two key features of the specialist nurse

role distinguished it from the roles of other health professionals

involved in prostate cancer care. These features

were: the availability of the specialist nurse to the patient,

and the ability of the specialist nurse to liaise between the

medical system and the patient.

The availability of the specialist nurse to the patient

Patients described the availability of the specialist nurse

firstly in terms of the amount of time the specialist nurse

was able to spend with them, and secondly in terms of the

specialist nurse's availability for contact throughout their

care.

Firstly, patients felt that the specialist nurse was able to

spend as much time with them as was needed, and that

their time with the nurse was not constrained. This was in

direct contrast with the consultant, who was seen as having

a limited consultation time. Having this time to talk

things over was particularly important for patients after

being given their diagnosis. The fact that specialist nurses

were available for as much time as the patient needed was

highly valued.

I had two, possibly, at least two meetings of hour and

a half, two hours ...discussing in detail all the possibilities,

all the options, my fears ...She did say herself,

take as long as you want, you know, I haven't booked

you down for a specific period of time and the first few

meetings did take an hour and a half, two hours.

Because I had so much to discuss with her (47)

Patients who did not see a specialist nurse after getting

their diagnosis highlighted the lack of unconstrained time

to talk things over, which had a negative emotional

impact on them.

So there I am ... fairly confirmed I would think at that

stage that I'm going to need cancer treatment, but noone

really to turn to. That was the thing, that in the

whole experience of this, that was the worst moment.

I needed somebody ...you know, in a ten minute

appointment [consultant]'d really stretched his

appointment time I'm sure to give me the benefit of

his knowledge ... But that's what I felt I needed, someone

to talk to, talk it through (14)

The timing of the consultation with the specialist nurse

was important: one patient described seeing the specialist

nurse immediately after being given the diagnosis, and

felt that this was too soon as he was still in shock following

the diagnosis.

Table 2: Characteristics of interviewed patients (n = 35)

Total number (%)

Age

55–70 13 (37.1)

70 or over 17 (48.6)up to 54 5 (14.3)

Ethnicity

South Asian 4 (11.4)

African/Caribbean 5 (14.3)White 26 (74.3)

Stage of disease/treatment

Being actively monitored without treatment 7 (20.0)

Had curative treatment (e.g. prostatectomy, radiotherapy) 17 (48.6)

Having hormone therapy 8 (22.9)Newly diagnosed (not yet treated) 3 (8.6)

BMC Health Services Research

Page 5 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

No you can't absorb it and that's in a way was one little

criticism of [specialist] nurse ... 'you've got prostate

cancer' ... and she carts you off into a tiny little cubicle

of a room ...and I don't know what the hell she said

because ...that was too soon ...I was in a, in a state of

numbness anyway at that point and so I don't really

know what it was she was trying to achieve (19)

In contrast, one patient described how the specialist nurse

had been sensitive to his shock and given him time to

come to terms with the diagnosis.

She said to me 'well whatever you are told today you're

not gonna take it all in' so they gave me a booklet on

prostate cancer and treatments, what is involved and

whatever and I was told to go away and read it, and

then if I'd got any questions or you know things like

that... (54)

A second key aspect of availability that patients valued

was the possibility of contact with the specialist nurse for

advice and support throughout their care.

Patients were often given the specialist nurse's phone

number as a point of contact if they had any concerns or

questions. This meant that contact with the specialist

nurse was easy, and could be patient-initiated, so patients

Table 3: Odds ratios for questions on patient experience of care: comparison of responses from patients who did, and did not, see a

specialist nurse

Question Saw specialist nurse

Frequency of positive

responses/total responses (%)

Did not see specialist nurse

Frequency of positive

responses/total responses (%)

Age-adjusted odds ratio

ratio, (95% confidence interval)Odds

p value

1. Given enough written or printed

information about the test results

175/225 (77.8) 14/32 (43.8) 4.58 (2.01; 10.43) p < 0.001

2. Given enough written or printed

information about active treatment

163/195 (83.6) 14/25 (56.0) 3.73 (1.46; 9.56) p = 0.01

3. Given enough written or printed

information about watchful waiting/

active monitoring

127/160 (79.4) 8/22 (36.4) 6.69 (2.45; 18.25) p < 0.001

4. Doctor or nurse clearly explained

what treatment options would

involve

210/239 (87.9) 22/36 (61.1) 3.51 (1.54; 8.01) p = 0.003

5. Doctor or nurse discussed clearly

the possible side effects or

consequences of treatment options

195/239 (81.6) 26/36 (72.2) 1.47 (0.63; 3.45) p = 0.37

6. Doctor or nurse gave an

explanation of why the other

treatment options were not suitable

136/202 (67.3) 15/30 (50) 2.05 (0.92; 4.60) p = 0.08

7. Doctor or nurse offered written

or printed information about the

treatment options

170/250 (68.0) 11/37 (29.7) 3.90 (1.76; 8.63) p = 0.001

8. Doctor or nurse offered written

or printed information about the

side effects or consequences of the

treatment options

158/252 (62.7) 10/37 (27.0) 3.81 (1.71; 8.49) p = 0.001

9. Patient made decision about

which type of treatment to have

(alone or in partnership with a

health professional)

157/251 (62.5) 11/37 (29.7) 2.69 (1.18; 6.12) p = 0.02

10. Doctor or nurse involved patient

as much as wanted in the decision

about which treatment to have

192/237 (81.0) 23/34 (67.6) 1.69 (0.73; 3.88) p = 0.22

11. After the treatment decision had

been made, doctor or nurse told

patient they could discuss their

treatment decision again

152/235 (64.7) 10/34 (29.4) 3.78 (1.68; 8.53) p = 0.001

12. Doctor or nurse told patient

that they could change their mind

about which treatment to have

132/230 (57.4) 6/33 (18.2) 4.71 (1.82; 12.22) p = 0.001

13. Doctor or nurse gave patient

enough information about sources of

help (e.g. support group/charities)

226/252 (89.7) 16/37 (43.2) 9.36 (4.11; 21.34) p < 0.001

BMC Health Services Research

Page 6 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

could have access to support or information as and when

they needed it.

It worried me to death ...my mind were in like a whirl.

I felt, I had to ring... [specialist nurse], 'cause I ask, I

was asking myself questions I couldn't answer, you

know 'Why this? And why that?'...after I spoke to her I

felt a lot better ...Oh I can ring [specialist nurse] up any

time I want to (27)

Just having the contact number was seen as a source of

reassurance, whether or not the patient actually needed to

use it.

[You can] contact her any time you want to...That's

important that you can do that. What does it do, give

you sort of reassurance that if you've got a problem or

a concern that you can ring, that you know who to ring

(38)

Patients who did not have access to this relatively quick

and responsive source of support and information had to

wait until they had an opportunity, in a scheduled consultation,

to discuss issues of concern.

Interviewer: Would you find [contact number for specialist

nurse] useful?

Patient: Yes, I would really because if um, odd times

I've passed a bit of blood from the bowel and I could

ring up and say, 'is that natural?'... You've sort of,

you've got to wait till the next appointment, which is

three months apart, and that's if they don't cancel it

again or nowt (31)

The ability of the specialist nurse to liaise between the medical

system and the patient

The second unique aspect of the specialist nurse role was

that specialist nurses were seen as being in a position to

liaise between the medical system and the patient. This

involved firstly providing or restating information about

diagnosis and treatment in terms which were clearly

understandable to the patient, and secondly, acting as an

advocate for the patient to facilitate the care process.

Firstly, patients described specialist nurses as helping

them to understand and come to terms with their diagnosis

and treatment through translating medical information

in order to present it in an understandable way. This

involved communicating in a patient-centred way and

using non-medical language. Specialist nurses were also

seen as more likely to address wider issues than simply the

diagnosis and treatment, such as the impact of treatments

on patients' lifestyles.

Patient: She did explain what the effects of the treatments

are, the hormone therapy and so on...

Wife: She was down to earth, she didn't come up with

any, you know so many medical terms...and she came

up with a lot of practical things that perhaps the consultant

wouldn't think to say... the fact that it's affecting

your lifestyle (48)

Secondly, patients described this liaison role in terms of

specialist nurses acting on their behalf to short-cut delays

in care, to gain more information for them, and even to

access particular medical services.

She can fiddle about and bang heads in the administration

and get things happening (48)

There is two specialist nurses there, I've got their numbers,

I speak to them and if there's anything else they

will speak to the consultant and then they'll get back

to me (54)

I said 'I want... [test]'...My surgeon said ' [patient

name] does not require [test]'...But she got it, she got

it through another um, consultant (49)

Where specialist nurses were involved in patient support

groups, this helped to facilitate this informal liaison role.

When we go to our [patient support] meetings if I say

to the oncology nurse ... 'well I've been a little bit worried

because...' so she says 'ok don't worry about it I'll

see Mr. so and so in the morning I'll give you a ring'

(1)

Discussion

Results from the questionnaire survey indicate that

patients who saw a specialist nurse were more likely to

have received written information and clear explanations

about their tests and treatment options, and about sources

of help and support. Patients who saw a specialist nurse

were more likely to say that they had made the treatment

decision themselves.

The qualitative findings elaborate on and help to explain

these differences. In interviews, patients described the

contribution of the specialist nurse to their experiences of

care immediately post-diagnosis, as well as over the

longer term of their treatment and monitoring for prostate

cancer. The specialist nurse was primarily seen as providing

patients with time to talk and reflect on the diagnosis,

providing advice, information and support (including

information which could support the patient in making a

treatment decision), and in some cases helping to facilitate

the course of the patient's care. When patients did not

BMC Health Services Research

Page 7 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

see a specialist nurse, they experienced gaps in their care,

in particular, a lack of time to talk things over post-diagnosis,

and a lack of immediate access to advice and support

over the course of their care.

Importantly, patients' accounts highlight the unique features

of the specialist nurse role, which make it possible

for specialist nurses to contribute to patients' positive

experiences of care. Firstly, patients described the availability

of the specialist nurse, in terms of the amount of

time the specialist nurse was able to spend with them in

contrast with other medical staff such as consultants, and

the possibility of patient-initiated contact with the specialist

nurse. This concurs with Boxhall and Dougherty's

study [15] in which patients valued the extra time available

to them with specialist nurses compared to doctors.

The second unique aspect of the specialist nurse role was

that specialist nurses were seen as being in a position to

liaise between the medical system and the patient. This

included providing or restating information about diagnosis

and treatment in terms which were clearly understandable

to the patient, and acting as an advocate for the

patient to facilitate the care process. These two key aspects

of care have been advocated as important to the specialist

nurse role [16], and this study indicates that these aspects

of the role are recognised and valued by patients

The unique nature of the specialist nurse role, with their

level of availability to the patient and their position at the

interface between the patient and the health system, was

seen as enabling specialist nurses to address specific

patient needs. Some of these needs could not be met by

professionals in different roles, as other roles do not share

the unique characteristics of the specialist nurse role (for

example, consultants are not able to offer patients their

time for unlimited periods). Taken together, the findings

of the questionnaire survey and the qualitative interviews

suggest that specialist nurses make a unique and valuable

contribution to patient experience of prostate cancer care.

There are several limitations to the work reported here

which should be noted. Firstly, the questionnaire survey

was not a randomised controlled study of an intervention,

and there is a risk of selection bias. It is possible that

patients who did and did not see a specialist nurse differed

on factors which were not measured as part of the study.

For example, patients who did not see a specialist nurse

may have felt less need for nurse input, or may have had

more or less advanced disease. This may have had an

impact on the study findings, given that only 12.8% of

participants had not seen a specialist nurse. However it is

notable that the groups did not differ in terms of treatment

type or health status. Those who did not see a specialist

nurse were older than those who did, and it is

possible that some of the participants who did not see a

specialist nurse may have been given their diagnosis prior

to the widespread input of specialist nurses in care. The

survey involved a relatively small number of patients in

three hospitals, and responders to the survey were predominantly

White British. In addition there were considerable

numbers of missing responses on some questions.

Although the response rate to the survey was relatively

high, the 40% of invited patients who did not respond to

the survey may differ systematically to those who did

respond, for example, they may be older, or have more

advanced disease. Hence the generalisability of the survey

results may be limited. The interviews reported here did

not systematically explore the role of the specialist nurse;

rather this was an issue raised spontaneously by patients,

and the analysis is limited to the issues raised by patients.

Also, the sampling frame for interviews did not aim specifically

to sample those who did and did not see a specialist

nurse. The studies do not make a distinction between

different types of specialist nurse (e.g. urology specialist

nurse and prostate cancer specialist nurse). Nevertheless,

the quantitative and qualitative components of the study

present complementary findings that together demonstrate

the benefits reported by patients of specialist nurses.

Conclusion

In conclusion, this study indicates that specialist nurses

play an important and unique role in prostate cancer care,

and have a positive impact on patient experience. It is

essential that specialist nurses are supported in their

unique role, and that their input is not threatened by

financial and organisational pressures.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

The authors contributed to the article as follows: CT, PS

and RB designed the study. CT, PS and SA collected the

data. CT analysed the data with input from PS, SA and RB.

CT drew up the draft manuscript and PS, SA and RB contributed

to producing the final version.

Acknowledgements

The study was funded by the NHS Service Delivery and Organisation

National R&D Programme (SDO/77/2004). We would like to thank the

men, and their carers, who participated in this research, and the members

of staff at participating hospitals who helped with recruitment. We would

also like to thank Raj Gill for transcribing the patient interviews.

References

1. National Audit Office: Tackling Cancer: Improving the Patient Journey

London: House of Commons; 2005.

2. The Prostate Cancer Charity Specialist Nurse Programme

[http://www.prostate-cancer.org.uk/what/nurses.asp]

3. McIntosh J:

the clinical nurse specialist and nurse consultant role. Evaluating the evidence for further investment inNew

Publish with

scientist can read your work free of chargeBioMed Central and every

"BioMed Central will be the most significant development for

disseminating the results of biomedical research in our lifetime."

Sir Paul Nurse, Cancer Research UK

Your research papers will be:

available free of charge to the entire biomedical community

peer reviewed and published immediately upon acceptance

cited in PubMed and archived on PubMed Central

yours — you keep the copyright

Submit your manuscript here:

http://www.biomedcentral.com/info/publishing_adv.asp

BioMedcentral

BMC Health Services Research

Page 8 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65

(page number not for citation purposes)

Nursing Roles: Deciding the future for Scotland. Role Development Consensus

Conference: 17 & 18 November 2003. Edinburgh

4. Davies M, Dixon S, Currie CJ, Davis RE, Peters JR:

hospital diabetes specialist nursing service: a randomised

controlled trial.

5. Forbes A, While A, Mathes L, Griffiths P:

nurse programme.

6. National Institute for Clinical Excellence:

Improving Outcomes in Urological Cancers. The Manual. London

7.

www.prostatecharter.org.uk/about_charter.php]

8. Hill A: 2003:18-22.Evaluation of aDiabet Med 2001, 18:301-307.Evaluation of a MS specialistInt J Nurs Stud 2006, 43(8):985-1000.Guidance on Cancer Services:2002.The Prostate Cancer Charter for Action 2005 [http://Financial threat to CNSs. Cancer Nursing Practice 2006,

5(7):

9. Harrison S:

balance their books: some NHS trusts that are in deficit are

targeting their most expensive nurses, but are they making

matters worse?

10. Norton C, Porrett T:

Nursing

11. Neate J:

National Prostate Conference. 3rd November 2006. London

www.prostate-cancer.org.uk/docs/conference_06/speech_john.doc].

12. Richardson A:

Prostate Cancer Charity Specialist Nurse Programme.

Prostate Cancer Charity National Prostate Conference. 3rd November

2006. London

what/conference06/downloads/

Specialist_Prostate_Cancer_Nurses_-_Prof_Alison_Richardson.ppt].

13. Baker R, Sinfield P, Agarwal S, Tarrant C, Mellon JK, Steward W, Colman

A, Kockelbergh R, Sproston K:

Measures of the Patient Experience. Report for the National Co-ordinating

Centre for NHS Service Delivery and Organisation R&D

2007.

14. Ritchie J, Spencer L:

research.

RG. London: Routledge; 1994:173-194.

15. Boxhall S, Dougherty M:

role for men with prostate cancer.

16. The London and South East Lung Cancer Forum for Nurses:

on the role of the specialist nurse in supporting patients

with lung cancer. 12-13.The tide has turned for specialists as trusts try toNurs Stand 2006, 20(39):14-17.The state of GI nursing. Gastrointestinal2006, 4(7):8-9.The challenges of innovation. The Prostate Cancer Charity2006 [http://Findings from a Multi Method Evaluation of theThe2006 [http://www.prostate-cancer.org.uk/content/Prostate Cancer Care: ImprovingLondon: NCCSDO;Qualitative data analysis for applied policyIn Analysing Qualitative Data Edited by: Bryman A, BurgessAn evaluation of a specialist nursingUrol Nurs 2003, 23:148-152.GuidelinesEur J Cancer Care 2004, 13:344-348.

Pre-publication history

The pre-publication history for this paper can be accessed

here:

http://www.biomedcentral.com/1472-6963/8/65/prepub

Tags: nurse consultant